You searched for "macular"
Transient macular thinning with Densiron 68
4 August 2021
| Kurt Spiteri Cornish
|
Retina / Uvea / Vitreous
|
OCT, Retinal detachment, heavy silicone oil, macula
Densiron 68 is a heavy silicone oil (HSO) used to treat rhegmatogenous retinal detachments (RRD) with inferior retinal breaks. The authors compared changes in retinal thickness during and after the use of Densiron endotamponade, and looked at any association between...
Macular thickness after strabismus surgery
1 October 2016
| Fiona Rowe (Prof)
|
Paediatric Ophthalmology / Strabismus
The aim of this study was to determine whether strabismus surgery is associated with changes in macular thickness as detected by OCT. The study included 60 eyes of 30 patients with mean age of 28.9±14.2 years undergoing unilateral surgery. Mean...
Intravitreal aflibercept for diabetic macular oedema
1 December 2015
| Brian Ang
|
Ophthalmology
The VISTA and VIVID randomised phase 3 trial were designed to compare the efficacy and safety of intravitreal aflibercept injections versus laser photocoagulation for diabetic macular oedema (DMO). A total of 872 patients with centrally involving DMO were recruited, and...
The rarebit vision test for macular conditions
1 October 2015
| Nana Theodorou
|
Retina / Uvea / Vitreous
|
age-related macular degeneration, macula, macular oedema, rarebit, vision test, visual acuity
Rarebit testing is used to measure low degrees of neuro-visual damage and is available for free on the internet. It consists of a fixed bright light dot presented on a black background. During testing it is presented briefly at different...
Management of diabetic macular oedema (DMO)
1 February 2018
| Kurt Spiteri Cornish
|
Retina / Uvea / Vitreous
|
Anti-VEGF therapy, Diabetic macular edema, Steroids
The authors present guidelines on current diagnostic and therapeutic procedures in the management of DMO. Fluorescein angiography (FA) and optical coherence tomography (OCT) are recommended before starting treatment to help diagnose and stage DMO, and can be repeated if there...
Progression of macular atrophy in Stargardt disease
3 April 2024
| Ian Reekie
|
Retina / Uvea / Vitreous
The authors present a study of a cohort of patients with genetically proven ABCA4 gene mutation related Stargardt disease. They aimed to quantify the effect of lesion location and topography on disease progression using fundus autofluorescence imaging. One hundred and...
Reduced blood flow and age-related macular degeneration
1 August 2014
| Khadijah Basheer
|
Retina / Uvea / Vitreous
This was a prospective cross-sectional study assessing changes in blood flow velocity in patients with age-related macular degeneration (AMD) using a retinal function imager. Sixty eyes with wet AMD were compared to 53 control eyes and the average blood flow...
Macular oedema after cataract surgery in diabetic patients
1 December 2013
| Lorraine North
|
Retina / Uvea / Vitreous
The authors describe a multi-centre prospective observational study of 293 participants that underwent cataract surgery who all had diabetic retinopathy without definite central-involved macular oedema. Forty-five clinical sites took part throughout the United States. Patients were eligible if there was...
Vitreomacular traction and full thickness macular hole
Clinical scenario: A 64-year-old lady presented to the clinic with a few weeks history of sudden onset of metamorphopsia, central blur and reduced vision in her right eye. The ocular examination and ocular coherence tomography confirmed right eye focal vitreomacular...Ranibizumab for the treatment of age-related macular degeneration
1 April 2015
| Nana Theodorou
|
Retina / Uvea / Vitreous
This multicentre randomised prospective open label study compared 0.5 versus 2mg of ranibizumab in patients with submacular retinal pigment epithelial (RPE) detachment due to age-related macular degeneration. Four treatment regimens were used for the two strengths either monthly for 12...
Outcomes of treat & extend ranibizumab in diabetic macular oedema
1 October 2021
| Ed Rule
|
Retina / Uvea / Vitreous
|
Diabetic macular edema, Outcome predictor, Ranibizumab, Spectral-domain optical coherence tomography, Treat and extend
This study retrospectively evaluated 118 eyes of 87 patients who received ranibizumab in a treat and extend regimen for diabetic macular oedema (DMO). Data were collected for patients under follow-up for 24 months. After 24 months, patients gained a mean...
Prophylaxis for clinical macular oedema after phacoemulsification
1 February 2016
| Brian Ang
|
Cataract and Refractive
The authors report on a retrospective cohort study looking at three different prophylaxis methods for macular oedema after cataract surgery: 1) Topical prednisolone acetate (PA) alone; 2) Topical PA in combination with non-steroidal anti-inflammatory drug (NSAID); 3) Intraoperative subconjunctival injection...